Novel Clinical and Laboratorial Challenges in Aspergillosis
In recent years, research in the areas of <i>Aspergillus</i> and aspergillosis has continued to advance rapidly, including advancements in genomics, immunological studies, clinical areas, and diagnostic areas. Recently, new risk groups for the development of aspergillosis have emerged—pa...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/10/2/259 |
_version_ | 1797477830826655744 |
---|---|
author | Raquel Sabino Cristina Veríssimo |
author_facet | Raquel Sabino Cristina Veríssimo |
author_sort | Raquel Sabino |
collection | DOAJ |
description | In recent years, research in the areas of <i>Aspergillus</i> and aspergillosis has continued to advance rapidly, including advancements in genomics, immunological studies, clinical areas, and diagnostic areas. Recently, new risk groups for the development of aspergillosis have emerged—patients with influenza- or COVID-19-ssociated pulmonary aspergillosis. The rise and spread of antifungal resistances have also become a clinical concern in some geographic areas and have drawn the attention of clinicians due to difficulties in treating these infections. In this paper, a snapshot of these issues is presented, emphasizing these novel clinical and laboratorial challenges in the aspergillosis field and focusing on their actual relevance. |
first_indexed | 2024-03-09T21:23:19Z |
format | Article |
id | doaj.art-04704acf7e644b57a2a2d54f19813f3d |
institution | Directory Open Access Journal |
issn | 2076-2607 |
language | English |
last_indexed | 2024-03-09T21:23:19Z |
publishDate | 2022-01-01 |
publisher | MDPI AG |
record_format | Article |
series | Microorganisms |
spelling | doaj.art-04704acf7e644b57a2a2d54f19813f3d2023-11-23T21:13:19ZengMDPI AGMicroorganisms2076-26072022-01-0110225910.3390/microorganisms10020259Novel Clinical and Laboratorial Challenges in AspergillosisRaquel Sabino0Cristina Veríssimo1Reference Unit for Parasitic and Fungal Infections, Department of Infectious Diseases, National Institute of Health, 1649-016 Lisbon, PortugalReference Unit for Parasitic and Fungal Infections, Department of Infectious Diseases, National Institute of Health, 1649-016 Lisbon, PortugalIn recent years, research in the areas of <i>Aspergillus</i> and aspergillosis has continued to advance rapidly, including advancements in genomics, immunological studies, clinical areas, and diagnostic areas. Recently, new risk groups for the development of aspergillosis have emerged—patients with influenza- or COVID-19-ssociated pulmonary aspergillosis. The rise and spread of antifungal resistances have also become a clinical concern in some geographic areas and have drawn the attention of clinicians due to difficulties in treating these infections. In this paper, a snapshot of these issues is presented, emphasizing these novel clinical and laboratorial challenges in the aspergillosis field and focusing on their actual relevance.https://www.mdpi.com/2076-2607/10/2/259<i>Aspergillus</i>invasive aspergillosisantifungal resistancesCAPAIAPA |
spellingShingle | Raquel Sabino Cristina Veríssimo Novel Clinical and Laboratorial Challenges in Aspergillosis Microorganisms <i>Aspergillus</i> invasive aspergillosis antifungal resistances CAPA IAPA |
title | Novel Clinical and Laboratorial Challenges in Aspergillosis |
title_full | Novel Clinical and Laboratorial Challenges in Aspergillosis |
title_fullStr | Novel Clinical and Laboratorial Challenges in Aspergillosis |
title_full_unstemmed | Novel Clinical and Laboratorial Challenges in Aspergillosis |
title_short | Novel Clinical and Laboratorial Challenges in Aspergillosis |
title_sort | novel clinical and laboratorial challenges in aspergillosis |
topic | <i>Aspergillus</i> invasive aspergillosis antifungal resistances CAPA IAPA |
url | https://www.mdpi.com/2076-2607/10/2/259 |
work_keys_str_mv | AT raquelsabino novelclinicalandlaboratorialchallengesinaspergillosis AT cristinaverissimo novelclinicalandlaboratorialchallengesinaspergillosis |